Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 3 Pancreatic Neoplasms 3 Cholangiocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pharyngeal Neoplasms 1 Oropharyngeal Neoplasms 1 Oligometastatic Prostate Cancer 1 Mouth Neoplasms 1 Melanoma 1 Lung Diseases 1 Locally Advanced Pancreatic Cancer 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Liposarcoma 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Gemcitabine 87 Cisplatin 66 Cystectomy 38 pembrolizumab 34 Docetaxel 25 Nivolumab 24 durvalumab 21 Paclitaxel 19 Magnetic Resonance Spectroscopy 18 Radiotherapy 17 Mitomycin 17 Carboplatin 16 atezolizumab 15 Doxorubicin 14 Cystoscopy 14 BCG Vaccine 13 Surveys and Questionnaires 12 Standard of Care 12 avelumab 11 Sunitinib 10 tremelimumab 9 Transurethral Resection of Bladder 9 Ipilimumab 9 Filgrastim 9 Blood Specimen Collection 9 Specimen Handling 8 Neoadjuvant Therapy 8 Methotrexate 8 Methods 8 Early Intervention, Educational 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urinary Bladder Neoplasms × zimberelimab × Clear all

NCT06528483 2024-07-30

preSAVE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡